Evidence map›Paper›PMID 42624855›Full record

ArticleNature communications2026

Structural origins of species-specific differences in TRPV2 activation.

Tabea C Fricke, Ruth A Pumroy, Julia A Rocereta, José J De Jesús-Pérez, George Oprita, Marvin J A Meyer, Christine Herzog, Frank G Echtermeyer, Kerstin Hill, Andreas Leffler and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tabea C Fricke *Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Ruth A Pumroy *Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-6200-6083
Julia A Rocereta *Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-3142-7846
José J De Jesús-PérezDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
George OpritaDepartment of Anatomy, Physiology, and Biophysics, Faculty of Biology, University of Bucharest, Bucharest, Romania.ORCID http://orcid.org/0009-0007-6964-8998
Marvin J A MeyerDepartment of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0009-0004-5227-5652
Christine HerzogDepartment of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Frank G EchtermeyerDepartment of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany.
Kerstin HillRudolf Boehm Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany.ORCID http://orcid.org/0000-0003-1306-8824
Andreas LefflerDepartment of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany. leffler.andreas@mh-hannover.de.ORCID http://orcid.org/0000-0003-1121-6387
Vera Y Moiseenkova-BellDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. vmb@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-0589-4053

Funding

Structure and Function of TRPV channelsR35GM144120 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Vera Moiseenkova-Bell · 2022 to 2026
$4.2M
NIGMS NIH HHS R35 GM144120U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM144120
6 · The paper itself

Abstract

Transient receptor potential vanilloid 2 (TRPV2) is a broadly expressed ion channel implicated in diverse physiological and pathological processes. Despite strong conservation, human TRPV2 (hTRPV2) displays markedly reduced sensitivity to stimuli such as 2-aminoethoxydiphenyl borate (2-APB) and heat compared to rodent orthologs. Here we combine electrophysiology and cryo electron microscopy to define the basis of this species-dependent divergence. The structure of hTRPV2 is remarkably different at the voltage sensor-like domain (VSLD) compared to rodent channels and functional analyses show a graded activity profile between human, mouse and rat TRPV2 to a broad range of chemical and physical stimuli. Three residues located between S6 and the TRP domain tune this functional difference, as reciprocal substitutions exchange current phenotypes. hTRPV2 structures of this mutant reveal coupling between the mutation site and the VSLD as well as an additional binding site for 2-APB. Together, these findings define structural determinants of species-specific TRPV2 function.

Indexed as

Calcium ChannelsTRPV Cation ChannelsAnimalsBinding SitesBoron CompoundsCryoelectron MicroscopyHEK293 CellsHumansMiceModels, MolecularMutationProtein DomainsRatsSpecies Specificity2-aminoethoxydiphenyl borateBoron CompoundsCalcium ChannelsTRPV2 protein, humanTrpv2 protein, mouseTrpv2 protein, ratTRPV Cation Channels

Identifiers

PMID42624855
PMCPMC13494035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.